Herbas VPB

Print
EN | LT
LT - Empagliflozino terapiniai panaudojimo būdai
EN - THERAPEUTIC USES OF EMPAGLIFLOZIN

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. A61K 31/155 (2006.01)
A61K 31/522 (2006.01)
A61K 31/7048 (2006.01)
A61P 9/10 (2006.01)
A61P 3/10 (2006.01)
A61K 45/06 (2006.01)
European patent
(11) Number of the document 2981255
(13) Kind of document T
(96) European patent application number 14715274.8
Date of filing the European patent application 2014-04-03
(97) Date of publication of the European application 2016-02-10
(45) Date of publication and mention of the grant of the patent 2022-09-14
(46) Date of publication of the claims translation 2022-11-25
PCT application
(86) Number PCT/EP2014/056655
Date 2014-04-03
PCT application publication
(87) Number WO 2014/161918
Date 2014-10-09
Priority applications
(30) Number Date Country code
201361808807 P 2013-04-05 US
2812016 2013-04-10 CA
201361823041 P 2013-05-14 US
201361835809 P 2013-06-17 US
201361835811 P 2013-06-17 US
201461942301 P 2014-02-20 US
Inventors
(72)
BROEDL, Uli Christian , DE
CHERNEY, David , CA
DAIBER, Andreas , DE
VON EYNATTEN, Maximilian , DE
JOHANSEN, Odd-Erik , NO
KIM, Gabriel Woojai , DE
MAYOUX, Eric Williams , DE
MUENZEL, Thomas , DE
PERKINS, Bruce A. , CA
SALSALI, Afshin , US
SOLEYMANLOU, Nima , CA
WOERLE, Hans-Juergen , DE
Grantee
(73) Boehringer Ingelheim International GmbH , Binger Strasse 173, 55216 Ingelheim am Rhein, DE
Attorney or representative
(74) Reda ŽABOLIENĖ, METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius, LT
Title
(54) Empagliflozino terapiniai panaudojimo būdai
  THERAPEUTIC USES OF EMPAGLIFLOZIN
Last renewal fee
Payment date Validity (years) Amount
2025-03-24 12 289.00 EUR
Next renewal fee
2026-04-03